Lameness and leg disorders in broiler chickens increasingly affect producers economically.

Most of the lameness issues are attributable to bacterial origin, a condition known as bacterial chondronecrosis and osteomyelitis (BCO) or femoral head necrosis. The disease is most commonly caused by Staphylococcus aureus, but Escherichia coli, coagulase-negative Staphylococci and Enterococcus spp. are sometimes involved, as are, rarely, other bacteria.

PoultryStar® is a synbiotic product containing multi-strain, poultry-specific probiotic organisms with fructooligosaccharides. It has been shown to reduce the incidence of BCO in broilers by the series of scientific experiments conducted by Dr Robert Wideman, Professor of University of Arkansas. He will be presenting his further research on the pathogenesis of BCO and the best way to lower its incidence at a lunch seminar sponsored by Biomin during IPPE in Atlanta.

Following Dr Wideman, Dr Raj Murugesan, Poultry Specialist of Biomin, will present the results of various commercial broiler trials conducted in the US, evaluating the efficacy of PoultryStar in reducing BCO and increasing performance.

The presentations will be followed by a lunch with the speakers and discussion. The lunch seminar will be on 29 January at the Georgia International Convention Center, room B306 from 12:00-1:30pm.

Tel: +1 210 342 95 55 - www.biomin.net - [email protected].